Medivir invites to a conference call on new clinical data and further studies with MIV-818Read more
Abstract for MIV-818 phase 1b monotherapy for ESMO Congress publishedRead more
Medivir to present at the Wainwright Annual Global Investment ConferenceRead more
Quarterly report presentations
Medivir Corporate Governance documention.
Documentation from Medivir's Annual General Meetings.